All news
Medium ImpactPharma

Piramal Pharma's US facility clears FDA inspection

Piramal Pharma's US facility clears FDA inspection. Piramal Pharma Limited announced the successful closure of a US FDA inspection at its Sellersville, USA manufacturing facility. This confirms compliance with regulatory standards and reduces risk of supply disruptions. The outcome supports operational credibility and potential export scalability.

📊 STOCKS: PPL | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #FDA

#FDA#Inspection#Pharma
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.